TP53 and esophageal squamous cell carcinoma: Sensitivities of miR-1273f and miR-619-5p were 82.5% and 80.0% in all stage and 92.9% and 92.8% in stage I ESCC, which showed much better detection rates compared to those of anti-p53 antibodies (around 25% to 30% in all stage ESCC and around 20% in stage I ESCC)29,30.